Search Results for "Requip For Depression"
Original Source: A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.
We hypothesize that depressed patients who have not responded to their current antidepressant medication will respond to the addition of ropinirole to their current regimen at a rate better than placebo.
Matching Channels
Depression is a serious mental health condition, where sad feelings carry on for weeks or months and interfere with your life. The symptoms include feeling unhappy most of the time (but may feel a...
Major depression unipolar disorder
Seroquel, an atypical antipsychotic medication has annual sales of $3.1m (in 2009), and based on annual sales, ranks 5th in the world. It is produced by AstraZeneca Pharmaceuticals as a quetiapine f...
Mental health, although not being as obvious as physical health, is very important, causing great unhappiness to those affected, causing additional physical health problems and costing the economy m...
Matching News
GSK to pay £160k in Requip ruling
GSK to pay £160k in Requip ruling
Leading dopamine agonists will continue to dominate Parkinson's market
The leading dopamine agonists, pramipexole (Boehringer Ingelheim's MirapexMirapexinSifrolBI-Sifrol, generics; Mirapex ERMirapexin ERSifrol RetardMirapex LA) and ropinirole (GlaxoSmithKline's Requip, g...
Man Wins Suit Over Sex Addiction
Didier Jambart Claimed Drug Requip Caused Devastating Side Effects
Dr. Reddy's introduces generic REQUIP XL tablets in US
Dr. Reddy's Laboratories, an integrated pharmaceutical company, has introduced Ropinirole Hydrochloride XR (extended-release) tablets of strengths 2mg, 4mg, 6mg, 8mg, and 12mg.
Actavis receives FDA approval for Ropinirole ER Tablets
Actavis Group, an international generic pharmaceuticals company, today announced that it received US FDA approval of Ropinirole Extended-Release Tablets, 2mg, 4mg, 6mg, 8mg and 12mg, a generic equival...
Most Depression Patients Report Discrimination
More than three quarters of patients (79%) with depression have experienced discrimination because of their condition. Previous studies analyzing the association between depression and discrimination...
Pennsylvania depression management collaborative reduces depression by 58 percent for nursing home residents
Type of depression can ‘rub off’ on others
A new study with college roommates shows that a particular style of thinking that makes people vulnerable to depression can actually “rub off” on others, increasing their symptoms of depression si...
Matching PubMed Articles
Towards translational rodent models of depression.
Rodent models of depression have been developed in an effort to identify novel antidepressant compounds and to further our understanding of the pathophysiology of depression. Various rodent models of...
The objective of this study was to determine associations between displayed depression symptoms on Facebook and self-reported depression symptoms using a clinical screen. Public Facebook profiles of u...
Bupropion in the treatment of depression in Parkinson's disease.
ABSTRACTA 78-year-old female with a nine-year history of depression was hospitalized due to worsening depression and symptoms associated with Parkinson's disease (PD). Her motor abilities improved on...
Anxiety, depression, and comorbid anxiety and depression: risk factors and outcome over two years.
ABSTRACTBackground: This study aimed to determine: (1) the prevalence of depression, anxiety, and depression associated with anxiety (DA); (2) the risk factor profile of depression, anxiety, and DA; (...
The concept of 'vascular depression' implies that cardiovascular disease facilitates the onset or persistence of depression in later life, and that the natural course of depression should differ accor...
